These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38910753)

  • 1. Prevalence, Risk Factors, and Result Features in the Detection of Latent Tuberculosis Infection in Thai Healthcare Workers Using QuantiFERON-TB Gold Plus.
    Klayut W; Srisungngam S; Suphankong S; Sirichote P; Phetsuksiri B; Bunchoo S; Jakreng C; Racksas S; Uppapong B; Rudeeaneksin J
    Cureus; 2024 May; 16(5):e60960. PubMed ID: 38910753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.
    Almohaya A; Aldrees A; Akkielah L; Hashim AT; Almajid F; Binmoammar T; Barry MA
    Ann Saudi Med; 2020; 40(3):191-199. PubMed ID: 32493098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
    Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
    PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-tube assays for detecting latent tuberculosis infection in Thai healthcare workers.
    Rudeeaneksin J; Srisungngam S; Klayut W; Bunchoo S; Bhakdeenuan P; Phetsuksiri B
    Rev Inst Med Trop Sao Paulo; 2023; 65():e13. PubMed ID: 36753066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent Tuberculosis Infection among Healthcare Workers in Duhok Province: From Screening to Prophylactic Treatment.
    Almufty HB; Abdulrahman IS; Merza MA
    Trop Med Infect Dis; 2019 May; 4(2):. PubMed ID: 31126022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.
    Moon HW; Gaur RL; Tien SS; Spangler M; Pai M; Banaei N
    J Clin Microbiol; 2017 Jun; 55(6):1650-1657. PubMed ID: 28298455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus.
    Gallegos Morales EN; Knierer J; Schablon A; Nienhaus A; Kersten JF
    J Occup Med Toxicol; 2017; 12():12. PubMed ID: 28559919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Latent Tuberculosis among Healthcare Workers in an Egyptian Hospital Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test.
    Anwar MM; Ahmed DM; Elareed HR; Abdel-Latif RA; Sheemy MS; Kamel NM; Mohamed MF
    Indian J Occup Environ Med; 2019; 23(3):106-111. PubMed ID: 31920258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    Sabri A; Quistrebert J; Naji Amrani H; Abid A; Zegmout A; Abderrhamani Ghorfi I; Souhi H; Boucaid A; Benali A; Abilkassem R; Kmari M; Hassani A; Lahcen B; Siah S; Schurr E; Boisson-Dupuis S; Casanova JL; Lahlou A; Laatiris A; Louzi L; Ouarssani A; Bourazza A; Aouragh A; Mustapha B; Messaoudi N; Agader A; Cobat A; Abel L; El Baghdadi J
    PLoS One; 2019; 14(8):e0221081. PubMed ID: 31415649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance.
    Szturmowicz M; Broniarek-Samson B; Demkow U
    J Occup Med Toxicol; 2021 Sep; 16(1):38. PubMed ID: 34470622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    Kim OH; Jo KW; Park S; Jo YH; Kim MN; Sung H; Shim TS
    PLoS One; 2020; 15(6):e0234700. PubMed ID: 32544206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of
    Xu Y; Yang Q; Zhou J; Zhou F; Hezhang Y; Gao Y; Shao L; Shi J; Ruan Q; Zhang W
    Microbiol Spectr; 2022 Apr; 10(2):e0187021. PubMed ID: 35234509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.